» Articles » PMID: 38637560

Somatic Mutations of Esophageal Adenocarcinoma: a Comparison Between Black and White Patients

Abstract

Esophageal adenocarcinoma is the most common histological subtype of esophageal cancer in Western countries and shows poor prognosis with rapid growth. EAC is characterized by a strong male predominance and racial disparity. EAC is up to fivefold more common among Whites than Blacks, yet Black patients with EAC have poorer survival rates. The racial disparity remains largely unknown, and there is limited knowledge of mutations in EAC regarding racial disparities. We used whole-exome sequencing to show somatic mutation profiles derived from tumor samples from 18 EAC male patients. We identified three molecular subgroups based on the pre-defined esophageal cancer-specific mutational signatures. Group 1 is associated with age and NTHL1 deficiency-related signatures. Group 2 occurs primarily in Black patients and is associated with signatures related to DNA damage from oxidative stress and NTHL1 deficiency-related signatures. Group 3 is associated with defective homologous recombination-based DNA often caused by BRCA mutation in White patients. We observed significantly mutated race related genes (LCE2B in Black, SDR39U1 in White) were (q-value < 0.1). Our findings underscore the possibility of distinct molecular mutation patterns in EAC among different races. Further studies are needed to validate our findings, which could contribute to precision medicine in EAC.

Citing Articles

Pre-Surgical Endoscopic Biopsies Are Representative of Esophageal and Esophago-Gastric Junction Adenocarcinoma Histologic Classes and Survival Risk.

Gambella A, Fiocca R, Lugaresi M, DErrico A, Malvi D, Spaggiari P Cancers (Basel). 2024; 16(23).

PMID: 39682231 PMC: 11640587. DOI: 10.3390/cancers16234045.

References
1.
Choi Y, Heath E, Heitmiller R, Forastiere A, Wu T . Mutations in beta-catenin and APC genes are uncommon in esophageal and esophagogastric junction adenocarcinomas. Mod Pathol. 2000; 13(10):1055-9. DOI: 10.1038/modpathol.3880194. View

2.
Secrier M, Li X, de Silva N, Eldridge M, Contino G, Bornschein J . Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance. Nat Genet. 2016; 48(10):1131-41. PMC: 5957269. DOI: 10.1038/ng.3659. View

3.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

4.
Weaver J, Ross-Innes C, Shannon N, Lynch A, Forshew T, Barbera M . Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis. Nat Genet. 2014; 46(8):837-843. PMC: 4116294. DOI: 10.1038/ng.3013. View

5.
Oh E, Choi Y, Kwon M, Kim R, Kim Y, Song J . Comparison of Accuracy of Whole-Exome Sequencing with Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tissue Samples. PLoS One. 2015; 10(12):e0144162. PMC: 4671711. DOI: 10.1371/journal.pone.0144162. View